Status
Conditions
Treatments
About
The purpose of the study is to evaluate the efficacy of a novel low-cost warming device to provide thermal care for newborn babies with hypothermia in low-resource hospitals. During the study, research participants will receive thermal care via the Celsi Warmer. Aside from thermal treatment, research participants will receive the standard of care from the neonatal unit, and will also be closely monitored by study personnel throughout the study. The results from this study will allow us to determine if the Celsi Warmer is an effective tool for warming and monitoring newborns in wards of low-resource hospitals. The research team hopes to demonstrate that the Celsi Warmer is effective for the appropriate treatment of newborn hypothermia in hospitals in low-resource settings.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Is currently being treated at study location
Is an inborn admission to the neonatal ward
Whose parents or guardians provided a written informed consent
Whose parents or guardians providing informed consent are 18 years old or older
Has a current weight of greater than or equal to 1.0 kg and less than or equal to 4.0kg
Has been identified as in need of thermal care defined as having a moderate hypothermic temperature (32.0-36.0°C) as the last temperature recorded in hospital chart, or during recruitment procedures; and
Is unable to be enrolled in KMC for reasons including, but not limited to:
May be receiving other medical treatments, including but not limited to, CPAP, oxygen therapy, IV fluids, management and monitoring of common newborn conditions such as hypoglycemia, and/or hyperbilirubinemia via LED phototherapy
Exclusion criteria
Requires mechanical ventilation
deemed in need of intensive care by the hospital staff who is providing care,including but not limited to:
Has been diagnosed with birth asphyxia
Presents a condition that precludes the use of the temperature sensor and/or abdominal belt including but not limited to, gastroschisis, known umbilical cord infection, known skin infection
Whose clinician presents concerns about their participation
Is receiving treatment that participation in the study would interfere with, i.e.transferring to KMC
Primary purpose
Allocation
Interventional model
Masking
90 participants in 1 patient group
Loading...
Central trial contact
Natalie Mitchell; Sonia Sosa Saenz, BME
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal